- Salary
- $250k – $265k/yr
- Location
- Boston, MA
- Workplace
- Hybrid
- Type
- Full-time
- Department
- Commercial
- Seniority
- Director
- Experience
- 8+ years
- Education
- PhD
- Source
- Lever
Description
OPENING
enGene (NASDAQ: ENGN) is a late-stage biotechnology company, mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com.
Role
We are seeking a highly strategic and hands-on Sr. Director, Insights & Analytics to lead the development and execution of our data-driven commercial insights capabilities. This role will drive the generation of actionable insights across commercial, medical affairs, and market access functions, enabling evidence-based decisions that shape our launch strategy and long-term growth. The ideal candidate is equally comfortable partnering with cross-functional leaders, and diving into complex datasets to uncover meaningful trends.